Stoke Therapeutics, Inc. (STOK)
29.42
+0.42
(+1.45%)
USD |
NASDAQ |
Jun 09, 14:11
Stoke Therapeutics Total Liabilities (Quarterly) : 48.40M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Recursion Pharmaceuticals, Inc. | 314.75M |
| Agenus, Inc. | 414.44M |
| Amgen, Inc. | 83.31B |
| BioCryst Pharmaceuticals, Inc. | 1.019B |
| Imunon, Inc. | 4.659M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 443.28M |
| Shareholders Equity (Quarterly) | 394.88M |
| Debt to Equity Ratio | 0.0087 |
| Current Ratio | 8.986 |
| Net Debt Paydown Yield | 0.01% |